---
figid: PMC9425441__ijms-23-08283-g007
pmcid: PMC9425441
image_filename: ijms-23-08283-g007.jpg
figure_link: /pmc/articles/PMC9425441/figure/ijms-23-08283-f007/
number: Figure 7
figure_title: ''
caption: 'Homeostasis-modifying treatments in hemostasis. Replacement therapies: recombinant
  factors, fresh frozen plasma, Octaplas®, recombinant ADAMTS13, and adeno-associated
  viruses. Nonreplacement therapies: desmopressin; emicizumab; caplacizumab (anti-vWF);
  and immunomodulators, such as prednisone and rituximab. Rebalancing therapies: fitusiran,
  concizumab, marstacimab, and serpinPC. Anticoagulant therapies: DOACs. Antifibrinolytic
  therapies: tranexamic acid and β-aminocaproic acid. vWF, von Willebrand factor;
  FVIII, factor VIII; FV, factor V; FIX, factor IX; FX, factor X; TTP, thrombotic
  thrombocytopenic purpura; vWD, von Willebrand’s disease; FFP, fresh frozen plasma;
  AT-III, antithrombin III; TFPI, tissue factor pathway inhibitor; APC (PC), activated
  protein C; PS, protein S; DOACs, direct oral anticoagulants; rADAMTS13, recombinant
  ADAMTS13. (+), activation; (–), inhibition.'
article_title: 'The Vascular Endothelium and Coagulation: Homeostasis, Disease, and
  Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V.'
citation: Juan A. De Pablo-Moreno, et al. Int J Mol Sci. 2022 Aug;23(15):8283.
year: '2022'

doi: 10.3390/ijms23158283
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI

keywords:
- vascular endothelium
- coagulation
- embryo
- von Willebrand factor
- factor VIII
- factor V
- homeostasis
- coagulopathies
- treatment

---
